U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214142) titled 'Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer' on Sept. 25.
Brief Summary: Research Objective:To investigate the efficacy and safety of the "total neoadjuvant chemoradiotherapy combined with immunotherapy" regimen for the treatment of locally advanced rectal cancer with high-risk features for recurrence.
Study Design:A single-arm, multicenter clinical study.
Study Population: Patients with locally advanced rectal cancer presenting with high-risk features for local recurrence.
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Rectal Cancer Patients
Intervention:
DRUG: PD-1
patients wil...